{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:09:09Z","timestamp":1784905749222,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s11427-025-3239-x","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T06:26:33Z","timestamp":1778480793000},"page":"2727-2741","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumor cell-intrinsic TET3 restrains type I interferon signaling and anti-tumor immunity"],"prefix":"10.1007","volume":"69","author":[{"given":"Lu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianbao","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinze","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiang Geno","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"3239_CR1","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1158\/2159-8290.CD-13-0458","volume":"4","author":"T Bald","year":"2014","unstructured":"Bald, T., Landsberg, J., Lopez-Ramos, D., Renn, M., Glodde, N., Jansen, P., Gaffal, E., Steitz, J., Tolba, R., Kalinke, U., et al. (2014). Immune cell-poor melanomas benefit from PD-1 blockade after targeted type I IFN activation. Cancer Discov 4, 674\u2013687.","journal-title":"Cancer Discov"},{"key":"3239_CR2","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41580-021-00430-1","volume":"23","author":"YG Chen","year":"2022","unstructured":"Chen, Y.G., and Hur, S. (2022). Cellular origins of dsRNA, their recognition and consequences. Nat Rev Mol Cell Biol 23, 286\u2013301.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3239_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/2658727","volume":"2022","author":"JD Chi","year":"2022","unstructured":"Chi, J.D., Zhang, W., Li, Y.G., Zhao, J., Zheng, X.Q., Gao, M., and Damante, G. (2022). TET3 mediates 5hmC level and promotes tumorigenesis by activating AMPK pathway in papillary thyroid cancer. Int J Endocrinol 2022, 1\u201313.","journal-title":"Int J Endocrinol"},{"key":"3239_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.stem.2011.08.007","volume":"9","author":"L Cimmino","year":"2011","unstructured":"Cimmino, L., Abdel-Wahab, O., Levine, R.L., and Aifantis, I. (2011). TET family proteins and their role in stem cell differentiation and transformation. Cell Stem Cell 9, 193\u2013204.","journal-title":"Cell Stem Cell"},{"key":"3239_CR5","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.immuni.2022.06.022","volume":"55","author":"I Cobo","year":"2022","unstructured":"Cobo, I., Tanaka, T.N., Chandra Mangalhara, K., Lana, A., Yeang, C., Han, C., Schlachetzki, J., Challcombe, J., Fixsen, B.R., Sakai, M., et al. (2022). DNA methyltransferase 3 alpha and TET methylcytosine dioxygenase 2 restrain mitochondrial DNA-mediated interferon signaling in macrophages. Immunity 55, 1386\u20131401.e10.","journal-title":"Immunity"},{"key":"3239_CR6","doi-asserted-by":"publisher","first-page":"eaap7309","DOI":"10.1126\/sciadv.aap7309","volume":"4","author":"E Collignon","year":"2018","unstructured":"Collignon, E., Canale, A., Al Wardi, C., Bizet, M., Calonne, E., Dedeurwaerder, S., Garaud, S., Naveaux, C., Barham, W., Wilson, A., et al. (2018). Immunity drives TET1 regulation in cancer through NF-\u03baB. Sci Adv 4, eaap7309.","journal-title":"Sci Adv"},{"key":"3239_CR7","doi-asserted-by":"publisher","first-page":"W534","DOI":"10.1093\/nar\/gkaf388","volume":"53","author":"H Cui","year":"2025","unstructured":"Cui, H., Zhao, G.L., Lu, Y.W., Zuo, S.Y., Duan, D.Y., Luo, X.B., Zhao, H., Li, J., Zeng, Z. X., Chen, Q.M., et al. (2025). TIMER3: an enhanced resource for tumor immune analysis. Nucleic Acids Res 53, W534\u2013W541.","journal-title":"Nucleic Acids Res"},{"key":"3239_CR8","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.1038\/s41467-020-18054-y","volume":"11","author":"S Damal Villivalam","year":"2020","unstructured":"Damal Villivalam, S., You, D., Kim, J., Lim, H.W., Xiao, H., Zushin, P.J.H., Oguri, Y., Amin, P., and Kang, S. (2020). TET1 is a beige adipocyte-selective epigenetic suppressor of thermogenesis. Nat Commun 11, 4313.","journal-title":"Nat Commun"},{"key":"3239_CR9","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","volume":"360","author":"F Delhommeau","year":"2009","unstructured":"Delhommeau, F., Dupont, S., Valle, V.D., James, C., Trannoy, S., Mass\u00e9, A., Kosmider, O., Le Couedic, J.P., Robert, F., Alberdi, A., et al. (2009). Mutation in TET2 in myeloid cancers. N Engl J Med 360, 2289\u20132301.","journal-title":"N Engl J Med"},{"key":"3239_CR10","doi-asserted-by":"publisher","first-page":"11582","DOI":"10.1021\/ja505305z","volume":"136","author":"LJ Fu","year":"2014","unstructured":"Fu, L.J., Guerrero, C.R., Zhong, N., Amato, N.J., Liu, Y.H., Liu, S., Cai, Q., Ji, D.B., Jin, S.G., Niedernhofer, L.J., et al. (2014). Tet-mediated formation of 5-hydroxymethyl-cytosine in RNA. J Am Chem Soc 136, 11582\u201311585.","journal-title":"J Am Chem Soc"},{"key":"3239_CR11","doi-asserted-by":"publisher","first-page":"4126","DOI":"10.1158\/0008-5472.CAN-17-2082","volume":"78","author":"CR Good","year":"2018","unstructured":"Good, C.R., Panjarian, S., Kelly, A.D., Madzo, J., Patel, B., Jelinek, J., and Issa, J.P.J. (2018). TET1-mediated hypomethylation activates oncogenic signaling in triple-negative breast cancer. Cancer Res 78, 4126\u20134137.","journal-title":"Cancer Res"},{"key":"3239_CR12","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1158\/2159-8290.CD-23-0007","volume":"13","author":"AA Guirguis","year":"2023","unstructured":"Guirguis, A.A., Ofir-Rosenfeld, Y., Knezevic, K., Blackaby, W., Hardick, D., Chan, Y.C., Motazedian, A., Gillespie, A., Vassiliadis, D., Lam, E.Y.N., et al. (2023). Inhibition of METTL3 results in a cell-intrinsic interferon response that enhances antitumor immunity. Cancer Discov 13, 2228\u20132247.","journal-title":"Cancer Discov"},{"key":"3239_CR13","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/s43587-023-00505-y","volume":"3","author":"TT Hong","year":"2023","unstructured":"Hong, T.T., Li, J., Guo, L., Cavalier, M., Wang, T.L., Dou, Y.L., DeLaFuente, A., Fang, S.H., Guzman, A., Wohlan, K., et al. (2023). TET2 modulates spatial relocalization of heterochromatin in aged hematopoietic stem and progenitor cells. Nat Aging 3, 1387\u20131400.","journal-title":"Nat Aging"},{"key":"3239_CR14","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.cell.2013.11.020","volume":"155","author":"LL Hu","year":"2013","unstructured":"Hu, L.L., Li, Z., Cheng, J.D., Rao, Q.H., Gong, W., Liu, M.J., Shi, Y.G., Zhu, J.Y., Wang, P., and Xu, Y.H. (2013). Crystal structure of TET2-DNA complex: insight into TET-mediated 5mC oxidation. Cell 155, 1545\u20131555.","journal-title":"Cell"},{"key":"3239_CR15","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/nature09303","volume":"466","author":"S Ito","year":"2010","unstructured":"Ito, S., D\u2019Alessio, A.C., Taranova, O.V., Hong, K., Sowers, L.C., and Zhang, Y. (2010). Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 466, 1129\u20131133.","journal-title":"Nature"},{"key":"3239_CR16","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1126\/science.1210597","volume":"333","author":"S Ito","year":"2011","unstructured":"Ito, S., Shen, L., Dai, Q., Wu, S.C., Collins, L.B., Swenberg, J.A., He, C., and Zhang, Y. (2011). Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333, 1300\u20131303.","journal-title":"Science"},{"key":"3239_CR17","doi-asserted-by":"publisher","first-page":"W283","DOI":"10.1093\/nar\/gkaf423","volume":"53","author":"YJ Kang","year":"2025","unstructured":"Kang, Y.J., Pan, L.J., Liu, Y.Y., Rong, Z.Q., Liu, J.X., and Liu, F.L. (2025). GEPIA3: enhanced drug sensitivity and interaction network analysis for cancer research. Nucleic Acids Res 53, W283\u2013W290.","journal-title":"Nucleic Acids Res"},{"key":"3239_CR18","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/ni1243","volume":"6","author":"T Kawai","year":"2005","unstructured":"Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H., Kato, H., Ishii, K.J., Takeuchi, O., and Akira, S. (2005). IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6, 981\u2013988.","journal-title":"Nat Immunol"},{"key":"3239_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/imr.12239","volume":"263","author":"M Ko","year":"2015","unstructured":"Ko, M., An, J., Pastor, W.A., Koralov, S.B., Rajewsky, K., and Rao, A. (2015). TET proteins and 5-methylcytosine oxidation in hematological cancers. Immunol Rev 263, 6\u201321.","journal-title":"Immunol Rev"},{"key":"3239_CR20","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nature09586","volume":"468","author":"M Ko","year":"2010","unstructured":"Ko, M., Huang, Y., Jankowska, A.M., Pape, U.J., Tahiliani, M., Bandukwala, H.S., An, J., Lamperti, E.D., Koh, K.P., Ganetzky, R., et al. (2010). Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 468, 839\u2013843.","journal-title":"Nature"},{"key":"3239_CR21","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/ng.391","volume":"41","author":"SMC Langemeijer","year":"2009","unstructured":"Langemeijer, S.M.C., Kuiper, R.P., Berends, M., Knops, R., Aslanyan, M.G., Massop, M., Stevens-Linders, E., van Hoogen, P., van Kessel, A.G., Raymakers, R.A.P., et al. (2009). Acquired mutations in TET2 are common in myelodysplastic syndromes. Nat Genet 41, 838\u2013842.","journal-title":"Nat Genet"},{"key":"3239_CR22","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.cell.2012.07.033","volume":"150","author":"CG Lian","year":"2012","unstructured":"Lian, C.G., Xu, Y.F., Ceol, C., Wu, F.Z., Larson, A., Dresser, K., Xu, W.Q., Tan, L., Hu, Y.G., Zhan, Q., et al. (2012). Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 150, 1135\u20131146.","journal-title":"Cell"},{"key":"3239_CR23","doi-asserted-by":"crossref","unstructured":"Liang, X., Liu, H., Hu, H., Zhou, J., Abedini, A., Navarro, A.S., Klotzer, K.A., and Susztak, K. (2024). Genetic studies highlight the role of TET2 and INO80 in DNA damage response and kidney disease pathogenesis. bioRxiv, 578718.","DOI":"10.1101\/2024.02.02.578718"},{"key":"3239_CR24","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/s12859-023-05615-3","volume":"24","author":"CQ Liao","year":"2023","unstructured":"Liao, C.Q., and Wang, X. (2023). TCGAplot: an R package for integrative pan-cancer analysis and visualization of TCGA multi-omics data. BMC Bioinf 24, 483.","journal-title":"BMC Bioinf"},{"key":"3239_CR25","doi-asserted-by":"publisher","first-page":"e24855","DOI":"10.1016\/j.heliyon.2024.e24855","volume":"10","author":"YY Liu","year":"2024","unstructured":"Liu, Y.Y., Wu, J.Y., Chen, L.Z., Zou, J., Yang, Q., Tian, H.T., Zheng, D.T., Ji, Z.Q., Cai, J. H., Li, Z.Y., et al. (2024). ncRNAs-mediated overexpression of TET3 predicts unfavorable prognosis and correlates with immunotherapy efficacy in breast cancer. Heliyon 10, e24855.","journal-title":"Heliyon"},{"key":"3239_CR26","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.cell.2005.08.026","volume":"122","author":"SM McWhirter","year":"2005","unstructured":"McWhirter, S.M., tenOever, B.R., and Maniatis, T. (2005). Connecting mitochondria and innate immunity. Cell 122, 645\u2013647.","journal-title":"Cell"},{"key":"3239_CR27","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1200\/JCO.2010.32.7742","volume":"29","author":"KH Metzeler","year":"2011","unstructured":"Metzeler, K.H., Maharry, K., Radmacher, M.D., Mr\u00f3zek, K., Margeson, D., Becker, H., Curfman, J., Holland, K.B., Schwind, S., Whitman, S.P., et al. (2011). TET2 mutations improve the new european leukemianet risk classification of acute myeloid leukemia: a cancer and leukemia group B study. J Clin Oncol 29, 1373\u20131381.","journal-title":"J Clin Oncol"},{"key":"3239_CR28","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/nature04193","volume":"437","author":"E Meylan","year":"2005","unstructured":"Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartenschlager, R., and Tschopp, J. (2005). Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437, 1167\u20131172.","journal-title":"Nature"},{"key":"3239_CR29","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s43018-021-00185-w","volume":"2","author":"KL Morel","year":"2021","unstructured":"Morel, K.L., Sheahan, A.V., Burkhart, D.L., Baca, S.C., Boufaied, N., Liu, Y., Qiu, X., Ca\u00f1adas, I., Roehle, K., Heckler, M., et al. (2021). EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer. Nat Cancer 2, 444\u2013456.","journal-title":"Nat Cancer"},{"key":"3239_CR30","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1158\/0008-5472.CAN-21-3523","volume":"82","author":"D Pan","year":"2022","unstructured":"Pan, D., Bao, X.H., Hu, M.J., Jiao, M., Li, F., and Li, C.Y. (2022). SETDB1 restrains endogenous retrovirus expression and antitumor immunity during radiotherapy. Cancer Res 82, 2748\u20132760.","journal-title":"Cancer Res"},{"key":"3239_CR31","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s41375-021-01390-3","volume":"36","author":"AJ Pulikkottil","year":"2022","unstructured":"Pulikkottil, A.J., Bamezai, S., Ammer, T., Mohr, F., Feder, K., Vegi, N.M., Mandal, T., Kohlhofer, U., Quintanilla-Martinez, L., Sinha, A., et al. (2022). TET3 promotes AML growth and epigenetically regulates glucose metabolism and leukemic stem cell associated pathways. Leukemia 36, 416\u2013425.","journal-title":"Leukemia"},{"key":"3239_CR32","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.cell.2015.07.056","volume":"162","author":"D Roulois","year":"2015","unstructured":"Roulois, D., Yau, H.L., Singhania, R., Wang, Y.D., Danesh, A., Shen, S.Y., Han, H., Liang, G.N., Jones, P.A., Pugh, T.J., O\u2019Brien, C., and De Carvalho, D.D. (2015). DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts. Cell 162, 961\u2013973.","journal-title":"Cell"},{"key":"3239_CR33","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1182\/blood-2009-09-245381","volume":"115","author":"FX Schaub","year":"2010","unstructured":"Schaub, F.X., Looser, R., Li, S., Hao-Shen, H., Lehmann, T., Tichelli, A., and Skoda, R. C. (2010). Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms. Blood 115, 2003\u20132007.","journal-title":"Blood"},{"key":"3239_CR34","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","volume":"32","author":"WM Schneider","year":"2014","unstructured":"Schneider, W.M., Chevillotte, M.D., and Rice, C.M. (2014). Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol 32, 513\u2013545.","journal-title":"Annu Rev Immunol"},{"key":"3239_CR35","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.cell.2005.08.012","volume":"122","author":"RB Seth","year":"2005","unstructured":"Seth, R.B., Sun, L.J., Ea, C.K., and Chen, Z.J. (2005). Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-\u03baB and IRF3. Cell 122, 669\u2013682.","journal-title":"Cell"},{"key":"3239_CR36","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.3390\/cancers13092207","volume":"13","author":"YH Shen","year":"2021","unstructured":"Shen, Y.H., Liu, L., Wang, M.Y., Xu, B., Lyu, R., Shi, Y.G., and Tan, L. (2021). TET2 inhibits PD-L1 gene expression in breast cancer cells through histone deacetylation. Cancers 13, 2207.","journal-title":"Cancers"},{"key":"3239_CR37","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.cell.2018.05.052","volume":"174","author":"WQ Sheng","year":"2018","unstructured":"Sheng, W.Q., LaFleur, M.W., Nguyen, T.H., Chen, S.J., Chakravarthy, A., Conway, J. R., Li, Y., Chen, H., Yang, H., Hsu, P.H., et al. (2018). LSD1 ablation stimulates anti-tumor immunity and enables checkpoint blockade. Cell 174, 549\u2013563.e19.","journal-title":"Cell"},{"key":"3239_CR38","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1126\/science.1170116","volume":"324","author":"M Tahiliani","year":"2009","unstructured":"Tahiliani, M., Koh, K.P., Shen, Y.H., Pastor, W.A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L.M., Liu, D.R., Aravind, L., et al. (2009). Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930\u2013935.","journal-title":"Science"},{"key":"3239_CR39","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1158\/0008-5472.CAN-23-1082","volume":"84","author":"HR Tao","year":"2024","unstructured":"Tao, H.R., Jin, C., Zhou, L.Y., Deng, Z.Z., Li, X., Dang, W.Z., Fan, S.J., Li, B., Ye, F., Lu, J.Y., et al. (2024). PRMT1 inhibition activates the interferon pathway to potentiate antitumor immunity and enhance checkpoint blockade efficacy in melanoma. Cancer Res 84, 419\u2013433.","journal-title":"Cancer Res"},{"key":"3239_CR40","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41588-022-01252-3","volume":"55","author":"F Wu","year":"2023","unstructured":"Wu, F., Li, X., Looso, M., Liu, H., Ding, D., G\u00fcnther, S., Kuenne, C., Liu, S., Weissmann, N., Boettger, T., et al. (2023). Spurious transcription causing innate immune responses is prevented by 5-hydroxymethylcytosine. Nat Genet 55, 100\u2013111.","journal-title":"Nat Genet"},{"key":"3239_CR41","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1158\/0008-5472.CAN-14-3208","volume":"75","author":"MZ Wu","year":"2015","unstructured":"Wu, M.Z., Chen, S.F., Nieh, S., Benner, C., Ger, L.P., Jan, C.I., Ma, L., Chen, C.H., Hishida, T., Chang, H.T., et al. (2015). Hypoxia drives breast tumor malignancy through a TET-TNF\u03b1-p38-MAPK signaling axis. Cancer Res 75, 3912\u20133924.","journal-title":"Cancer Res"},{"key":"3239_CR42","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.molcel.2005.08.014","volume":"19","author":"LG Xu","year":"2005","unstructured":"Xu, L.G., Wang, Y.Y., Han, K.J., Li, L.Y., Zhai, Z., and Shu, H.B. (2005). VISA is an adapter protein required for virus-triggered IFN-\u03b2 signaling. Mol Cell 19, 727\u2013740.","journal-title":"Mol Cell"},{"key":"3239_CR43","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.molcel.2011.04.005","volume":"42","author":"YF Xu","year":"2011","unstructured":"Xu, Y.F., Wu, F.Z., Tan, L., Kong, L.C., Xiong, L.J., Deng, J., Barbera, A.J., Zheng, L.J., Zhang, H.K., Huang, S., et al. (2011). Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. Mol Cell 42, 451\u2013464.","journal-title":"Mol Cell"},{"key":"3239_CR44","doi-asserted-by":"publisher","first-page":"4316","DOI":"10.1172\/JCI129317","volume":"129","author":"YP Xu","year":"2019","unstructured":"Xu, Y.P., Lv, L., Liu, Y., Smith, M.D., Li, W.C., Tan, X., Cheng, M., Li, Z.J., Bovino, M., Aub\u00e9, J., et al. (2019). Tumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy. J Clin Invest 129, 4316\u20134331.","journal-title":"J Clin Invest"},{"key":"3239_CR45","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.3802\/jgo.2024.35.e64","volume":"35","author":"F Xue","year":"2024","unstructured":"Xue, F., Liu, L., Tao, X., and Zhu, W. (2024). TET3-mediated DNA demethylation modification activates SHP2 expression to promote endometrial cancer progression through the EGFR\/ERK pathway. J Gynecol Oncol 35, e64.","journal-title":"J Gynecol Oncol"},{"key":"3239_CR46","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.celrep.2016.06.068","volume":"16","author":"SJ Xue","year":"2016","unstructured":"Xue, S.J., Liu, C., Sun, X.J., Li, W.Y., Zhang, C., Zhou, X., Lu, Y., Xiao, J., Li, C.Y., Xu, X.Y., et al. (2016). TET3 inhibits type I IFN production independent of DNA demethylation. Cell Rep 16, 1096\u20131105.","journal-title":"Cell Rep"},{"key":"3239_CR47","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12935-023-03021-6","volume":"23","author":"LY Yang","year":"2023","unstructured":"Yang, L.Y., Zhao, R.Y., Qiao, P.P., Cui, J.X., Chen, X.P., Fan, J.P., Hu, A., and Huang, S.X. (2023). The novel oncogenic factor TET3 combines with AHR to promote thyroid cancer lymphangiogenesis via the HIF-1\u03b1\/VEGF signaling pathway. Cancer Cell Int 23, 206.","journal-title":"Cancer Cell Int"},{"key":"3239_CR48","doi-asserted-by":"publisher","first-page":"1418456","DOI":"10.3389\/fphar.2024.1418456","volume":"15","author":"CY Zhang","year":"2024","unstructured":"Zhang, C.Y., Zheng, J., Liu, J., Li, Y.X., Xing, G.Q., Zhang, S.P., Chen, H.K., Wang, J., Shao, Z.J., Li, Y.Y., et al. (2024). Pan-cancer analyses reveal the molecular and clinical characteristics of TET family members and suggests that TET3 maybe a potential therapeutic target. Front Pharmacol 15, 1418456.","journal-title":"Front Pharmacol"},{"key":"3239_CR49","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/cr.2010.156","volume":"20","author":"HK Zhang","year":"2010","unstructured":"Zhang, H.K., Zhang, X., Clark, E., Mulcahey, M., Huang, S., and Shi, Y.G. (2010). TET1 is a DNA-binding protein that modulates DNA methylation and gene transcription via hydroxylation of 5-methylcytosine. Cell Res 20, 1390\u20131393.","journal-title":"Cell Res"},{"key":"3239_CR50","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nature15252","volume":"525","author":"Q Zhang","year":"2015","unstructured":"Zhang, Q., Zhao, K., Shen, Q.C., Han, Y.M., Gu, Y., Li, X., Zhao, D.Z., Liu, Y.Q., Wang, C.M., Zhang, X., et al. (2015). Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6. Nature 525, 389\u2013393.","journal-title":"Nature"},{"key":"3239_CR51","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/s41586-024-07969-x","volume":"634","author":"Z Zou","year":"2024","unstructured":"Zou, Z., Dou, X., Li, Y., Zhang, Z., Wang, J., Gao, B., Xiao, Y., Wang, Y., Zhao, L., Sun, C., et al. (2024). RNA m5C oxidation by TET2 regulates chromatin state and leukaemogenesis. Nature 634, 986\u2013994.","journal-title":"Nature"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-025-3239-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11427-025-3239-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-025-3239-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:36:00Z","timestamp":1784903760000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11427-025-3239-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["3239"],"URL":"https:\/\/doi.org\/10.1007\/s11427-025-3239-x","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"13 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest. The study was approved by the Institutional Animal Care and Use Committee of Shanghai Pudong Hospital (Approval No. 2024-MS-D-29). All animal experiments were conducted in accordance with the National Guidelines for Animal Usage.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance and ethics"}}]}}